Antiretroviral Therapy Current Events | Antiretroviral Therapy News | 6
|
| Page
6 of
36 |
712 Results |
|
|
|
Sort By:
Page Views | Date |
Study highlights risky behavior, lack of care among HIV-infected crack users
Doctors who treat HIV-infected crack users refer to them as "the forgotten population." A study being presented at this week's International AIDS Conference in Mexico City reveals that these patients frequently lack outpatient health care, do not receive life-saving antiretroviral therapy and continue to engage in risky sexual behavior... view more... (2008-08-05)
Inappropriate sepsis therapy leads to fivefold reduction in survival
Patients experiencing septic shock who receive inappropriate therapy may have a fivefold reduction in survival, shows a new study. view more (2009-11-05)
Landmark study defines benefits of early HIV testing and treatment for infected infants
Testing very young babies for HIV and giving antiretroviral therapy (ART) immediately to those found infected with the virus dramatically prevents illness and death, according to a report in the New England Journal of Medicine. view more (2008-11-20)
Nurses safely and effectively prescribe antiretroviral drugs in pilot program
Given sufficient training and support, nurses can safely and effectively prescribe antiretroviral therapy (ART) to patients with HIV, according to a Rwandan study published in this week's PLoS Medicine. view more (2009-10-13)
Viral 'fitness' explains different resistance patterns to aids drugs
Some HIV medications lead to the development of drug-resistant HIV when patients take as few as two percent of their medications. view more (2006-01-11)
New hope for HIV sufferers as immunosuppressant delays AIDS onset
A drug that suppresses the immune system delays the onset of AIDS in patients with HIV, according to a study published this week in BMC Medicine. Prednisolone, taken without any antiviral therapy, postponed the loss of T-cells that leads to AIDS in 50% of HIV sufferers by between 2 and 10 years. HIV leads to a complex disorder that combines an... view more... (2004-04-30)
Challenges of HIV-1 subtype diversity
A review article in the New England Journal of Medicine explores the genetic variation of HIV-1 and its implications for preventing and treating the disease. Francine McCutchan, Ph.D., a researcher with the U.S. Military HIV Research Program, co-authored the article, which appeared in the April 10, 2008 edition. view more (2008-05-22)
AIDS study challenges conventional treatment guidelines for HIV patients
A newly published study by investigators at the Center for AIDS Research at Case Medical Center, led by Benigno RodrÃguez, MD, along with a nationwide team of AIDS/HIV experts, strongly challenges conventional thinking about the role of measurements of the amount of HIV particles in the blood as a method of predicting a patient's ability to fight... view more... (2006-09-27)
Further evidence for effectiveness of nevirapine in reducing mother-to-child HIV-1 transmission (pp 842, 859)
Issue 13 September 2003 Embargoed 0001 h (London time) 12 September 2003. A follow-up study among mothers with HIV-1 and their infants in this week's issue of THE LANCET provides further evidence for the sustained efficacy of nevirapine as a low-cost option to help prevent vertical HIV-1 transmission from mothers to newborn children in... view more... (2003-09-10)
Protein identified that turns off HIV-fighting T cells
In HIV-infected patients the body's immune system is unable to fight off the virus. A new study to be published online on November 10th in the Journal of Experimental Medicine shows that T cells in HIV-infected individuals express a protein called TIM-3, which inactivates their virus killing capacity. view more (2008-11-10)
'Resonance' may explain virologic failure in STI drug therapy
Researchers have been puzzled over why HIV-positive patients who have periodic, built in interruptions in their drug therapy reach a point where the therapy no longer reduces their viral loads, even in the absence of any evidence of acquired drug resistance. view more (2006-04-14)
HIV-1 : RECOMBINATION BETWEEN TWO STRAINSFROM WIDELY DISTANT GROUPS
Scientists have known for a long time that the AIDS virus is genotypically highly variable. Two main types of the virus exist: HIV-1 and HIV-2. HIV-1, the most widespread throughout the world, can be divided into three groups (M, N and O) each of which has different genetic characteristics. Within group M, which gathers together the most frequent... view more... (2000-03-09)
HIV dementia alarmingly high in Africa
An international study led by Johns Hopkins suggests that the rate of HIV-associated dementia is so high in sub-Saharan Africa that HIV dementia along with Alzheimer's disease and dementia from strokes may be among the most common forms of dementia in the world. view more (2007-01-30)
Many pregnant women avoid HIV screening in Africa
'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission. view more (2009-11-20)
Higher risks for women with diabetes using HRT
Women with diabetes who use hormone replacement therapy are at an increased risk of death from all causes and heart disease, finds a study in this week’s BMJ. view more (2003-02-19)
Fat on chest and upper back increases risk of insulin resistance
Upper trunk fat -- deposits of fat on the chest and back -- is associated with an increased risk of insulin resistance, a condition that is a precursor of type 2 diabetes, according to a study led by researchers at the San Francisco VA Medical Center (SFVAMC). view more (2007-08-20)
Delay in use of nevirapine-based AIDS treatment can improve outcomes
Delaying the use of nevirapine-containing antiretroviral therapy (ART) for at least six months after labor may improve treatment outcomes among HIV-infected women in developing countries who took nevirapine during labor to prevent their babies from becoming infected, suggests a new study in The New England Journal of Medicine. view more (2007-01-11)
Questions over 'healing effect' of magnet therapy
Patients should be advised that magnet therapy has no proved benefits, and that any healing effect is likely to be small, say US researchers in this week's BMJ. view more (2006-01-06)
Treatment outcomes of patients with HIV and tuberculosis
In a retrospective study of 700 patients with culture-positive tuberculosis (TB), relapse rates were found to be significantly higher in HIV-infected patients compared to HIV-uninfected patients following a rifamycin-based regimen. view more (2007-06-01)
Aids: A Single-Tablet Generic Tritherapy Tested Successfully In Cameroon
WHO's objective is to enable 3 million people living with HIV to have access to antiretroviral treatments by 2005. The development of simple and inexpensive generic fixed-dose combined therapies appears the most suitable solution for making possible this access to treatments in developing countries with meagre resources. The tritherapies that... view more... (2004-07-01)
|
|
| Page
6 of
36 |
712 Results |
|
|
|
Sort By:
Page Views | Date |
|
